Evidence map›Paper›PMID 26260861›Full record

ArticleTransfusion2015

2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium.

Steven L Spitalnik, Darrell Triulzi, Dana V Devine, Walter H Dzik, Anne F Eder, Terry Gernsheimer, Cassandra D Josephson, Daryl J Kor, Naomi L C Luban, Nareg H Roubinian and 5 more

Abstract read
In one paragraph

Article in Transfusion, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. [The current situation and the future of pediatric blood transfusion].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Hitchhiker's guide to the red blood cell storage lesion.Blood transfusion = Trasfusione del sangue · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Steven L SpitalnikDepartment of Pathology & Cell Biology, Columbia University Medical Center-New York Presbyterian Hospital, New York, New York.
Darrell TriulziInstitute for Transfusion Medicine and Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Dana V DevineCanadian Blood Services and the Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada.
Walter H DzikDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Anne F EderNational Headquarters, American Red Cross, Rockville, Maryland.
Terry GernsheimerDepartment of Medicine, University of Washington, Seattle, Washington.
Cassandra D JosephsonDepartment of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
Daryl J KorDepartment of Anesthesiology, Mayo Clinic College of Medicine, Rochester, Minnesota.
Naomi L C LubanDivision of Laboratory Medicine, Center for Cancer and Blood Disease, Children's National Health System, and the Department of Pediatrics, George Washington University School of Medicine, Washington, DC.
Nareg H RoubinianBlood Systems Research Institute, and the Department of Laboratory Medicine, University of California, San Francisco, California.
Traci MondoroDivision of Blood Diseases and Resources, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland.
Lisbeth A WelniakDivision of Blood Diseases and Resources, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland.
Shimian ZouDivision of Blood Diseases and Resources, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland.
Simone GlynnDivision of Blood Diseases and Resources, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland.
State of the Science in Transfusion Medicine Working Groups

Funding

REGULATION OF LACTOSAMINYL GLYCAN BIOSYNTHESIS IN HEMATOPOIETIC CELLSP01HL107146 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SACKSTEIN, ROBERT · 2011 to 2017
$17.7M
Carbohydrate-Mediated Platelet ClearanceR01HL089224 · NHLBI · VERSITI WISCONSIN, INC. · PI Karin Maria Hoffmeister · 2007 to 2026
$9.3M
SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)R01GM113838 · NIGMS · WASHINGTON UNIVERSITY · PI DOCTOR, ALLAN, MCMAHON, TIMOTHY J · 2015 to 2019
$4.0M
Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary ComplicationsR01HL121232 · NHLBI · MAYO CLINIC ROCHESTER · PI KOR, DARYL J, WELSBY, IAN J · 2014 to 2018
$3.2M
Harmful effects of red blood cell transfusions are mediated by ironR01HL115557 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SPITALNIK, STEVEN L · 2013 to 2016
$2.3M
The human glucocorticoid receptor and normal and pathological terminal erythroidR01HL116329 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MIGLIACCIO, ANNA RITA F · 2012 to 2015
$1.7M
NHLBI NIH HHS P01 HL107146NHLBI NIH HHS R01 HL089224NHLBI NIH HHS R01 HL115557NHLBI NIH HHS R01 HL116329NHLBI NIH HHS R01 HL121232NIGMS NIH HHS R01 GM113838
6 · The paper itself

Abstract

On March 25 and 26, 2015, the National Heart, Lung, and Blood Institute sponsored a meeting on the State of the Science in Transfusion Medicine on the National Institutes of Health (NIH) campus in Bethesda, Maryland, which was attended by a diverse group of 330 registrants. The meeting's goal was to identify important research questions that could be answered in the next 5 to 10 years and which would have the potential to transform the clinical practice of transfusion medicine. These questions could be addressed by basic, translational, and/or clinical research studies and were focused on four areas: the three "classical" transfusion products (i.e., red blood cells, platelets, and plasma) and blood donor issues. Before the meeting, four working groups, one for each area, prepared five major questions for discussion along with a list of five to 10 additional questions for consideration. At the meeting itself, all of these questions, and others, were discussed in keynote lectures, small-group breakout sessions, and large-group sessions with open discourse involving all meeting attendees. In addition to the final lists of questions, provided herein, the meeting attendees identified multiple overarching, cross-cutting themes that addressed issues common to all four areas; the latter are also provided. It is anticipated that addressing these scientific priorities, with careful attention to the overarching themes, will inform funding priorities developed by the NIH and provide a solid research platform for transforming the future practice of transfusion medicine.

Indexed as

Blood TransfusionAnimalsCongresses as TopicHumansNational Heart, Lung, and Blood Institute (U.S.)United States

Identifiers

PMID26260861
PMCPMC4573332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.